AGP Executive Report
Last update: 8 hours agoBiotech Deal: Antengene struck an exclusive licensing deal with K2 Therapeutics for ATG-106, a preclinical CDH6 x CD3 bispecific T cell engager, with about $20M upfront and up to $960.5M in milestones—another sign life sciences dealmaking is staying active. Education & Workforce: Massachusetts is weighing “universal FAFSA” style graduation requirements, pushing students to complete FAFSA/MASFA or file a low-barrier opt-out, a move aimed at keeping more families eligible for aid. Immigration Policy: The DHS is asking the First Circuit to pause a Massachusetts judge’s block of a proposed $100,000 H-1B fee, arguing the injunction could cause irreparable harm to enforcement. Local Transit & Growth: The South Coast Rail line is showing stronger-than-feared ridership and potential spillover benefits for Fall River and New Bedford, though continued MBTA service improvements and marketing are key. Healthcare Ops: Fujifilm Healthcare Americas opened an 18,000-square-foot endoscopy warehouse in Fairfield, N.J., to expand logistics and service capacity for its Lexington, Mass.-based endoscopy business. Sports Business: Celtics draft-pick retrospectives and fresh Giannis trade chatter keep Boston’s NBA economy buzz alive, while World Cup crowds are driving local hospitality demand and operational stress.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
